Closing Stock Market SummaryThe S&P 500 increased 0.3% on Friday, starting the second quarter on a positive note despite a more inverted Treasury yield curve. The Nasdaq Composite (+0.3%) and Dow Jones Industrial Average (+0.4%) also rose modestly while the Russell 2000 outperformed with a 1.0% gain.
Eight of the 11 S&P 500 sectors closed higher, led by the real estate (+2.0%), utilities (+1.5%), consumer staples (+1.3%), and materials (+1.1%) sectors. Conversely, the information technology (-0.2%), financials (-0.2%), and industrials (-0.7%) sectors underperformed in negative territory.
The tech sector was pressured by valuation concerns, as the 10-yr yield rose five basis points to 2.38%; the financials sector was pressured by an inversion of the 2s10s spread, as the 2-yr yield rose 15 basis points to 2.43%; and the industrials sector was pressured by weakness in its transportation components. The Dow Jones Transportation Average dropped 4.7%.
Treasury yields pushed higher in the wake of the March employment report, which showed decent jobs growth, a lower unemployment rate, and continued wage inflation -- a recipe for the Fed to hike rates by 50 basis points next month.
More specifically, nonfarm payrolls increased by 431,000 (Briefing.com consensus 475,000) on top of an upwardly revised 750,000 (from 678,000) in February. The unemployment rate improved to 3.6% (Briefing.com consensus 3.7%) from 3.8% in February. Average hourly earnings rose 0.4%, as expected.
Transport stocks were weak, supposedly because the employment report also showed a decrease in transportation jobs (-1,000) following large gains in the prior two months.
The 2s10s inversion once again turned the conversation to a potential recession caused by the Fed aggressively hiking rates into slower growth. On the latter, the March ISM Manufacturing Index decelerated to 57.1% (Briefing.com consensus 58.3%) from 58.6% in February.
Separately, oil prices ($99.54, -0.89, -0.9%) were pressured by news that other IEA nations like Europe, Canada, Mexico, Japan, and South Korea will join the U.S. in releasing oil from their reserves. WTI crude ended the week lower by 12.6%. The U.S. Dollar Index increased 0.3% to 98.56.
Reviewing Friday's economic data:
- The Employment Situation report for March showed a smaller than expected increase in nonfarm and private payrolls, which masked big upward revisions to readings from the past two months. Average hourly earnings showed an increase that was in-line with expectations, though average workweek decreased slightly.
- March nonfarm payrolls increased by 431,000 (consensus 475,000). The 3-month average for total nonfarm payrolls decreased to 562,000 from 614,000. February nonfarm payrolls revised to 750,000 from 678,000. January nonfarm payrolls revised to 504,000 from 481,000.
- March private sector payrolls increased by 426,000 (consensus 450,000). February private sector payrolls revised to 739,000 from 654,000. January private sector payrolls revised to 492,000 from 448,000.
- March unemployment rate was 3.6% ( consensus 3.7%) versus 3.8% in February.
- March average hourly earnings increased by 0.4% (consensus 0.4%) after increasing a revised 0.1% (from 0.0%) in February. Over the last 12 months, average hourly earnings have risen 5.6%, versus 5.1% for the 12 months ending in January.
- The average workweek in March was 34.6 hours (consensus 34.7) versus 34.7 hours in February.
- The labor force participation rate ticked up to 62.4% from 62.3% in February. The employment-population ratio rose to 60.1% from 59.9% in February.
- The key takeaway from the report is that while it showed a slowdown in hiring activity, wage growth continued and the unemployment rate returned to a pre-pandemic level, reflecting a tight job market. This combination is unlikely to deter the Fed from staying on what is expected to an aggressive rate hike path.
- The March ISM Manufacturing Index decreased to 57.1% (consensus 58.3%) from 58.6% in February. A number above 50.0% is indicative of expansion. March marked the 22nd consecutive month of expansion in the manufacturing sector.
- The key takeaway from the report is that activity slowed to its lowest pace since the end of 2020 while prices continued increasing, which suggests that inflation will continue running at a hot pace in the near term.
- Total construction spending increased 0.5% month-over-month in February ( consensus 1.0%) while the January reading was revised up to 1.6% (from 1.3%).
- The key takeaway from the report is that residential spending continued increasing, which was masked by a decrease in most public construction spending.
Looking ahead, investors will receive Factory Orders for February on Monday.
- Dow Jones Industrial Average -4.2% YTD
- S&P 500 -4.6% YTD
- Russell 2000 -6.9% YTD
- Nasdaq Composite -8.8% YTD
On their own, various segments of the curve that have each been relatively reliable recession indicators historically are implying very different probabilities of recession within the next 24 months. This unusually sharp divergence in the probabilities implied by curve segment is another indicator of the unusual structure of the current yield curve: very steep at the front of the curve, but flat/inverted further out.Combining indicators into a single model unsurprisingly improves the ability to predict recessions and implies that the market is currently pricing recession probabilities that are broadly consistent with the shape of the curve—close to no chance of recession in the next 12 months, but a higher risk of recession (38%) in the following year.
Subject: Briefing; CALLS; Research Calls
01-Apr-22 07:26 ETTICKER ALERT: CALLS
Research Calls
- Upgrades:
- Banco Santander (SAN) upgraded to Outperform from Neutral at Credit Suisse
- Caixabank (CAIXY) upgraded to Outperform from Neutral at Credit Suisse
- Centennial Resource Development (CDEV) upgraded to Buy from Hold at Stifel; tgt raised to $11.20
- Comerica (CMA) upgraded to Neutral from Sell at Goldman; tgt raised to $112
- Comerica (CMA) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $115
- Evotec SE (EVO) upgraded to Buy from Neutral at Kempen; tgt $15
- Tellurian (TELL) upgraded to Outperform from Neutral at Credit Suisse; tgt raised to $8
- Vertiv (VRT) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $18
- Downgrades:
- Amylyx Pharmaceuticals (AMLX) downgraded to Neutral from Buy at Goldman; tgt lowered to $10
- American Eagle (AEO) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $19
- BankUnited (BKU) downgraded to Neutral from Overweight at JP Morgan; tgt $50
- Blend Labs (BLND) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $5
- Blend Labs (BLND) downgraded to Hold from Buy at Canaccord Genuity; tgt lowered to $5
- Blend Labs (BLND) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $5.50
- Commscope (COMM) downgraded to Neutral from Buy at Goldman; tgt lowered to $9
- Dell (DELL) downgraded to Neutral from Conviction Buy at Goldman; tgt lowered to $61
- Ellington Residential Mtg (EARN) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
- First American Financial (FAF) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $74
- Gap (GPS) downgraded to Underweight from Equal Weight at Barclays; tgt lowered to $13
- NextDecade (NEXT) downgraded to Neutral from Outperform at Credit Suisse; tgt raised to $7.50
- Poshmark (POSH) downgraded to Hold from Buy at Stifel; tgt lowered to $15
- Qorvo (QRVO) downgraded to Neutral from Outperform at KGI Securities; tgt $140
- Science Applications (SAIC) downgraded to Hold from Buy at Truist; tgt $105
- Silverback Therapeutics (SBTX) downgraded to Hold from Buy at Stifel; tgt lowered to $6
- Silverback Therapeutics (SBTX) downgraded to Neutral from Buy at H.C. Wainwright
- UniFirst (UNF) downgraded to Underweight from Neutral at JP Morgan; tgt $178
- Urban Outfitters (URBN) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $29
- Walgreens Boots Alliance (WBA) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $51
- Wayfair (W) downgraded to Underweight from Equal Weight at Barclays; tgt $103
- Zimmer Biomet (ZBH) downgraded to Neutral from Buy at Citigroup; tgt raised to $135
- Others:
- 1Life Healthcare (ONEM) assumed with an Outperform at Credit Suisse; tgt $15
- Accolade (ACCD) assumed with an Outperform at Credit Suisse; tgt $33
- Agree Realty (ADC) initiated with an Overweight at Morgan Stanley; tgt $75
- AmerisourceBergen (ABC) assumed with an Outperform at Credit Suisse; tgt $180
- Amwell (AMWL) assumed with a Neutral at Credit Suisse; tgt $5
- Cano Health (CANO) assumed with an Outperform at Credit Suisse; tgt $13
- Cardinal Health (CAH) assumed with a Neutral at Credit Suisse; tgt $58
- Change Healthcare (CHNG) assumed with a Neutral at Credit Suisse; tgt $25.75
- Check Point Software (CHKP) initiated with a Buy at Summit Insights; tgt $160
- Definitive Healthcare (DH) assumed with a Neutral at Credit Suisse; tgt $24
- eHealth (EHTH) assumed with a Neutral at Credit Suisse; tgt $16
- Edwards Lifesciences (EW) added to Focus List at Citigroup
- GoHealth (GOCO) assumed with an Underperform at Credit Suisse; tgt $1.50
- GoodRx (GDRX) assumed with a Neutral at Credit Suisse; tgt $22
- Hims & Hers Health (HIMS) assumed with an Outperform at Credit Suisse; tgt $8
- ImaRx Therapeutics (IMRX) initiated with an Outperform at Oppenheimer; tgt $25
- McKesson (MCK) assumed with an Outperform at Credit Suisse; tgt $333
- MSCI (MSCI) initiated with a Neutral at Goldman; tgt $553
- Oracle (ORCL) initiated with a Neutral at Daiwa Securities; tgt $87
- Owens & Minor (OMI) assumed with a Neutral at Credit Suisse; tgt $43
- Premier (PINC) assumed with an Underperform at Credit Suisse; tgt $35
- Privia Health (PRVA) assumed with an Outperform at Credit Suisse; tgt $43
- Rain Therapeutics (RAIN) initiated with an Outperform at Oppenheimer; tgt $15
- SelectQuote (SLQT) assumed with a Neutral at Credit Suisse; tgt $4
- Snowflake (SNOW) initiated with a Neutral at SMBC Nikko; tgt $253
- SOC Telemed (TLMD) assumed with a Neutral at Credit Suisse; tgt $3
- Teladoc (TDOC) assumed with an Outperform at Credit Suisse; tgt $114
- Tivity Health (TVTY) assumed with a Neutral at Credit Suisse; tgt $31
- Upstart (UPST) initiated with an Equal-Weight at Stephens; tgt $124
- Vectrus (VEC) initiated with a Buy at Truist; tgt $65







